Biocon Limited has relieved Indranil Sen, Chief Financial Officer of the company, from his duties on March 14, 2024.

Sen is a Chartered Accountant from the Institute of Chartered Accountants of India (ICAI). Sen spent a decade with Biocon and held various key roles, including Controller, Head of Treasury, Tax, and Costing, progressing to become the Head of Business Finance – Small Molecules, and ultimately assuming the position of CFO.

He has also worked with Symphony Services Corp. India Private Limited as Director Finance, and he held important positions in statutory audit at KPMG, Ernst Young, and PWC.